Xcout IntelSign inSubscribe

Cencora

CORHealthcareConshohocken, United States

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Subscribe to see Cencora’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Cencora at a glance

Cencora is a healthcare company headquartered in Conshohocken, United States. It is publicly listed (COR) with a market capitalisation of $59.9B. Xcout tracks 30 named people at Cencora, including Robert Mauch (President, Chief Executive Officer & Director). Xcout recorded 1 job posting from Cencora in the last 90 days.

Industry
Healthcare
Headquarters
Conshohocken, United States
Market cap
$59.9B
Employees
51,000
Ticker
COR
Job postings recorded (90 days)
1

Cencora leadership

  • Robert MauchPresident, Chief Executive Officer & Director
  • Robert P. MauchPresident and Chief Executive Officer
  • Juan GuerraEVP and President, International Business Group
  • Richard TremonteEVP and President, U.S. Pharmaceuticals and Animal Health
  • Eva C BorattoExecutive Vice President & Chief Financial Officer
  • Eva BorattoExecutive Vice President and Chief Financial Officer

24 more named people on record for Cencora, with roles, board committees and tenure — see the full roster →

Hiring at Cencora

Xcout recorded 1 job posting from Cencora in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see Cencora's hiring signals →

Cencora competitors

A few of Cencora's closest competitors — see the full list of competitors and alternatives →

メディパルホールディングス7459 · PharmaceuticalsTokyo, Japan
65% matchPublic

Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.

Market cap$3.6B
Employees13,024
メディパルホールディングス competitors & alternatives →

Get Cencora's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Cencora — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Cencora in Xcout Intel

  • 30 named people with titles, LinkedIn and board committees
  • Weekly hiring history and the mix of roles behind it
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →